CAS Number: 1256589-74-8

Stage: Pipeline

Alectinib Hydrochloride is a highly selective ALK inhibitor indicated for ALK-positive non-small cell lung cancer (NSCLC). It effectively crosses the blood-brain barrier, providing control over CNS metastases. Alectinib HCl is a preferred first-line therapy in targeted NSCLC treatment due to its superior efficacy and tolerability. Explore Royal Pharma as your potential partner for Alectinib HCl API.